Navigation Links
NBTY Acquisition of Julian Graves Referred to U.K. Competition Commission
Date:3/20/2009

RONKONKOMA, N.Y., March 20 /PRNewswire-FirstCall/ -- NBTY, Inc. (NYSE: NTY) (www.NBTY.com), a leading global manufacturer and marketer of nutritional supplements, today announced that its acquisition of Julian Graves has been referred in the United Kingdom by the Office of Fair Trading to the Competition Commission.

NBTY's subsidiary, NBTY Europe, purchased Julian Graves, a chain of 350 food and confectionary stores in the U.K., on September 16, 2008, for approximately $25 million USD.

As previously announced, the Julian Graves acquisition was the subject of an inquiry from the Office of Fair Trading for potential anti-trust implications. In conjunction with this inquiry, Julian Graves has not been integrated with the Company's European operations.

The Office of Fair Trading's decision to refer the Julian Graves acquisition to the Competition Commission can be found on its web site: www.oft.gov.uk. According to the Office of Fair Trading, the Competition Commission is expected to report by September 3, 2009.

ABOUT NBTY

NBTY is a leading global vertically integrated manufacturer, marketer and distributor of a broad line of high-quality, value-priced nutritional supplements in the United States and throughout the world. Under a number of NBTY and third party brands, the Company offers over 22,000 products, including products marketed by the Company's Nature's Bounty(R) (www.NaturesBounty.com), Vitamin World(R) www.VitaminWorld.com),

SOURCE NBTY, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Parties in Los Gatos Hospital Acquisition Agree on Terms Allowing El Camino Hospital an Early Close of Escrow
2. Tepnel Shareholders Approve Acquisition by Gen-Probe
3. NeuroFocus Expands Into the UK and Europe Through Acquisition of Neuroco
4. RoundTable Healthcare Partners Completes Portfolio Company Add-On Acquisition
5. Devicor Medical Products Actively Seeking First Acquisition
6. Apex Bioventures Acquisition Corp. To Seek Stockholder Approval To Liquidate and Dissolve
7. China Healthcare Acquisition Corp. Announces Stockholder Approval of Charter Amendment to Permit Early Distribution of Its Trust Fund and to Permit Its Continued Existence Without Blank Check Company Provisions and Sets Payment Date
8. NDC Completes Acquisition of Phase One Medical(R) Anchoring Technology
9. RoundTable Healthcare Partners Leads Portfolio Company Add-On Acquisition
10. Abbott Completes Acquisition of Advanced Medical Optics
11. Access Pharmaceuticals Closes Acquisition of MacroChem Corp.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...s has announced that it has become a national spon...t nonprofit organizations dedicated to arthritis r... Delray Beach, FL (Vocus) November 27... company specializing in the marketing and retail ...announced today that is has become a national spon...
(Date:11/27/2009)...ade; announced today that Spectrum Health (Grand R...rise orthopedic templating solution and its Trauma... (PRWEB) November 27, 2009 -- Voyant Health&... Rapids, Michigan) has licensed its TraumaCad Ente...maCad Extend workflow solution, to allow its ortho...
(Date:11/26/2009)... -- With cold and flu season upon us, it,s more im...rol the spread of infections and avoid illness. ,...elves healthy, but to avoid transmitting illness i...ertified in infection-control), nursing director f...spital for Special Surgery (HSS) in Manhattan. ,...
(Date:11/26/2009)...ad to strains or worse , , THURSDAY, Nov...g with stuffing your turkey full to bursting, but ...suitcase as you pack for holiday trips. , More ...spital emergency rooms, doctors, offices, clinics ...njuries, such as muscle strains, pulls and tears, ...
(Date:11/26/2009)...e Dental (RTDental), a leading dental group practi...expansion of its services to include LUMINEERS by ... , Durham, NC (PRWEB) -...that Dr. Doug Macmillan, an experienced LUMINEERS...ed training seminar. RTDental’s ability to ...
Breaking Medicine News(10 mins):Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2
... , , WASHINGTON, March 23 Claire Franzen of Cent...y, March 29 through Tuesday, March 31, 2009 to mee...t for epilepsy public health programs and more res...ogram coordinated by the Epilepsy Foundation and f...
... F.A. Davis unveils DavisPT...at the APTA Combined Sections Meeting. The site fe... physical therapy continuing education courses (co... to announce the launch of DavisPTnetwork.com, a n...
... , , , , , WASHINGTON, March 23 David Rollick..., Sunday, March 29 through Tuesday, March 31, 2009... support for epilepsy public health programs and m...onal program coordinated by the Epilepsy Foundatio...
... PEMBROKE, Bermuda, March 23 Darwin National,As...Assurance Company,Holdings, Ltd (NYSE: AWH ), to...sident, Risk Management, will moderate a panel at ...n? Exploring the Risks,of Contaminated Medical Pro...
...Many people of East Asian descent possess an enzym...flush, when they drink alcohol. Scientists from t...ism (NIAAA) and Japan,s Kurihama Alcohol Center no...world,s population. Their review of recent researc...
... , , WASHINGTON, March 23 Alexandria Gray of Chi... March 29 through Tuesday, March 31, 2009 to meet ...for epilepsy public health programs and more resea...coordinated by the Epilepsy Foundation and funded ...
Other Medicine News:Health News:Colorado Youth Shares Epilepsy Message on Capitol Hill 2Health News:New Online Network Features Continuing Education Courses for Physical Therapists 2Health News:Virginia Youth Shares Epilepsy Message on Capitol Hill 2Health News:Darwin to Moderate Panel at Plus Medical Symposium 2Health News:Darwin to Moderate Panel at Plus Medical Symposium 3Health News:Alcohol 'flush' signals increased cancer risk among East Asians 2Health News:Alcohol 'flush' signals increased cancer risk among East Asians 3Health News:Illinois Youth Shares Epilepsy Message on Capitol Hill 2
(Date:11/25/2009)...wire-FirstCall/ -- ERT (Nasdaq: ERES ), announced... President and CEO, and Keith Schneck, the Company... to present at the 21st Annual Piper Jaffray Healt...09 in New York City, New York. ,, Interested pa...Company,s corporate website at http://www.ert.com...
(Date:11/25/2009)...ire/ -- The FDA granted traditional approval for I...ide reverse transcriptase inhibitor (NNRTI). INTEL...use in treatment-experienced adults who are experi...ant to an NNRTI and other antiretroviral (ARV) age... data from two Phase 3 studies known as DUET-1 and...
(Date:11/25/2009)...RNewswire/ -- AMPAC Fine Chemicals LLC (AFC), a su... APFC ) announced today that it received the Envir...t the Annual Statewide Environmental Summit, spons...y Association (CMTA), the Industrial Environmental...il of California (CICC) held in San Diego. This i...
Breaking Medicine Technology:ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 3Stem Cells Grow Heart Tissue in Lab 59556 1Stem Cells Grow Heart Tissue in Lab 59556 2Stem Cells Grow Heart Tissue in Lab 59556 3Medical Transcription Services Provider MxSecure Names Healthcare IT Expert Mark McLaughlin New Chief Technology Officer 59553 1Medical Transcription Services Provider MxSecure Names Healthcare IT Expert Mark McLaughlin New Chief Technology Officer 59553 2Medical Transcription Services Provider MxSecure Names Healthcare IT Expert Mark McLaughlin New Chief Technology Officer 59553 3Astrup Drug Implements ECRS Retail Solution Suite to Address Diverse Business Requirements 59550 1Astrup Drug Implements ECRS Retail Solution Suite to Address Diverse Business Requirements 59550 2
...inary Phase II Results Encouraging and Support Pha...ternational,Inc. (NYSE: BAX ) and The Alzheimer,s...unced the decision to pursue a multi-center U.S. P...quid [Immune Globulin Intravenous,(Human)] (IGIV),...e,treatment of patients with mild to moderate alzh...
...rack to have Phase 3 data available by the spring ...tion applications expected by the ...28 Human Genome,Sciences, Inc. (Nasdaq: HGSI ) t...d initial dosing ahead of schedule in ACHIEVE 1, t...n(R) (albinterferon alfa-2b) in,combination with r...
Other Medicine Technology:Baxter and The Alzheimer's Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimer's Disease 2Baxter and The Alzheimer's Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimer's Disease 3Baxter and The Alzheimer's Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimer's Disease 4Baxter and The Alzheimer's Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimer's Disease 5Baxter and The Alzheimer's Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimer's Disease 6Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule 2Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule 3Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule 4Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule 5
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
Medicine Products: